Código QR (código de barras bidimensional)

A Novel HDAC6 Inhibitor Enhances the Efficacy of Paclitaxel Against Ovarian Cancer Cells

Ovarian cancer cells overexpress HDAC6, and selective HDAC6 inhibitors have been considered potential new drugs for ovarian cancer either alone or in combination with other anticancer agents. We screened 46 potential novel HDAC6 inhibitors in ES-2 ovarian cancer cells and showed that compound <b>252...

Fuld beskrivelse

Na minha lista:
Principais autores: An-Jui Chi, Jui-Ling Hsu, Yun-Xin Xiao, Ji-Wang Chern, Jih-Hwa Guh, Chao-Wu Yu, Lih-Ching Hsu
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2025-06-01
Serier:Molecules
Fag:
HDAC6 inhibitor
paclitaxel (Taxol)
ovarian cancer
combination therapy
apoptosis
Online adgang:https://www.mdpi.com/1420-3049/30/13/2793
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker